Sharescart Research Club logo
Products
Research
Tools
About
ChatGPT Claude Perplexity
Summarize with
ChatGPT Claude Perplexity
Join Channel
Apollo Green₹ 72 (28.6%)ASK Investment₹ 895 (-3.2%)AVPL ₹ 49 (0%)Bootes Impex₹ 775 (-8.8%)CIAL ₹ 442 (-0.5%)CSK ₹ 254 (-3.1%)ESDS Software₹ 478 (2.8%)Garuda Aerospace₹ 468 (-2.1%)Goodluck Defence₹ 385 (16%)Hero Motors₹ 325 (0%)Hinduja Leyland₹ 248 (0%)ICL Fincorp₹ 25 (0%)Incred Holdings₹ 154 (2.7%)Kineco Limited₹ 3285 (0%)Lava ₹ 60 (15.4%)Market Simplified₹ 26 (-7.1%)Matrix Gas₹ 12 (-20%)Motilal Oswal₹ 12.25 (-2%)MSEI ₹ 6.35 (-2.3%)NCDEX ₹ 368 (-1.6%)NSE ₹ 1985 (-2%)Onix Renewable₹ 68 (21.4%)OYO ₹ 23 (-4.2%)OYO Assets₹ 9.25 (-7%)Philips India₹ 1250 (0%)Polymatech Electronics₹ 56 (-3.4%)SBI Mutual₹ 768 (-0.9%)Taparia Tools₹ 6050 (0%)VCI Chemical₹ 64 (0%)Zepto ₹ 40 (-4.8%)

15 Days Price Change

Sheel Biotech IPO

Closing In

  • days
  • Hours
  • Minutes
  • Seconds

WEBSITE Inc. Year: 1991 Industry: Agriculture Listed Page

Profile
Issue Size 24.42 Cr
Profile
Price Range 59  to  63 per share
Profile
Min Investment ₹63
Profile
Lot Size 1
Profile
Face Value ₹10
Profile
Draft Prospectus
Invest Before the IPO Goes Live

Buy unlisted shares early and participate in the growth before public listing.

Profile
  • Basic Info
  • IPO Tentative Timetable
  • IPO Lot Size
  • Subscription Status
  • Financials
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Ratios
  • Growth Rates
  • Other info

Overview

Our Company is engaged in the business of growing, developing, processing, and supplying a wide range ofplants for field crops, fruits, vegetables, and ornamental plants through tissue culture and organic farming. Wemanufacture and maintain greenhouses, offer services to farmers and provide training through Farmer ProducerOrganizations (FPOs). Additionally, we deliver green landscaping services to both government and privatesectors. We are an ISO 9001:2015, ISO 14001:2015 & ISO 45001:2018 certified company and is managed byindustry experts and professionals with knowledge in the field of Biotechnology, Agriculture, Floriculture,Horticulture, Tissue Culture and Green Houses. The company also has a Research and Development lab with acapacity of production of 10 million* planting materials which is duly recognized by the Department ofBiotechnology (DBT), Government of India. Read More

Basic Info

Face Value 10 per share

Price 59  to  63 per share

P/E (x) 8.8

Sales( Cr.) 102

PAT( Cr.) 11

EPS 7.2

Draft Prospectus

Exchange NSE-SME

Promoter

Company Promoters

Satya Narayan Chandak Sanjay Chandak Divye Chandak Mini Chadha Satya Narayan Chandak (HUF) Sanjay Chandak (HUF) Sumeet Chandak (HUF)

Pre Issue Share Holding 96.99%

Post Issue Share Holding 71.26%

Listing Details:

Listing Price: 91

Listing Gain: 30.77%

Current Price: 43.2

Gain On Issue: 43.2 | 0%

GMP: --

GMP %: -- %

IPO Tentative Timetable

Opening Date Sep 30, 2025
Closing Date Oct 03, 2025
Allotment Oct 06, 2025
Refund Oct 07, 2025
Delivery of Shares Oct 07, 2025
Listing Date Oct 08, 2025

IPO Lot Size

Application Lots Shares Amount
Retail (Min) 1 4000 252,000
Retail (Max) -- -- --
S-HNI (Min) 1 4000 252,000
S-HNI (Max) 3 12000 756,000
B-HNI (Min) 4 16000 1,008,000

Objective of the Issue

1. To meet our the Capital Expenditure requirements of the company2. To meet out the expenses for Working capital requirement for the company3. To meet out the expenses for General Corporate Purpose

Issue

Category Nos Bid Bid (x)
QIB 0 20244000 0x
NII 0 20352000 0x
Retail 0 17260000 0x
EMP 0 0 0x
Total 0 57856000 0x

Net Sales (in cr.)

Total Income (in cr.)

Operating Profit (in cr.)

Net Profit (in cr.)

Shareholder Funds (in cr.)

Total Assets (in cr.)

Sheel Biotech Profit & Loss

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 68 70 71 60 61 61 63 71 80 92 102
Other Income 0 0 0 0 0 0 0 0 0 0 1
Total Income 68 70 71 61 61 61 63 71 80 93 102
Total Expenditure 61 62 63 53 53 54 57 64 71 78 87
Operating Profit 7 8 8 8 8 7 7 7 9 15 15
Interest 1 1 1 1 1 2 1 1 2 1 2
Depreciation 1 1 1 1 1 1 1 1 1 1 1
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 5 6 6 6 6 4 5 5 6 12 13
Provision for Tax 1 0 0 0 0 0 0 0 1 2 2
Profit After Tax 5 6 5 5 6 4 5 5 5 10 11
Adjustments 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 5 6 5 5 6 4 5 5 5 10 11
Adjusted Earnings Per Share 3.4 3.8 3.8 3.7 4.4 3 3.3 3.1 3.5 7.2 7.1

Sheel Biotech Balance Sheet

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 30 35 39 44 49 53 57 60 64 73 84
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 2 1 0 1 4 8 12 13 9 10 5
Other Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0 1
Total Current Liabilities 20 23 27 16 17 21 13 20 21 23 24
Total Liabilities 52 59 67 61 70 81 82 93 94 106 113
Fixed Assets 8 8 8 8 8 8 8 8 8 7 7
Other Non-Current Assets 0 0 0 0 0 1 1 2 3 3 5
Total Current Assets 44 51 59 53 63 72 74 83 83 95 101
Total Assets 52 59 67 61 70 81 82 93 94 106 113

Sheel Biotech Cash Flow

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 0 0 0 0 0 0 0 0 0 0 1
Cash Flow from Operating Activities -2 2 4 -1 0 -0 0 2 9 -1 9
Cash Flow from Investing Activities -3 -1 -0 -1 -0 -1 0 -2 -2 -0 -2
Cash Flow from Financing Activities 4 -1 -4 1 -0 2 0 -0 -7 2 -7
Net Cash Inflow / Outflow -0 0 0 -0 0 0 0 -0 -0 0 -0
Closing Cash & Cash Equivalent 0 0 0 0 0 0 0 0 0 1 0

Sheel Biotech Ratios

# Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 3.37 3.84 3.78 3.71 4.43 3.05 3.31 3.11 3.5 7.22 7.11
CEPS(Rs) 3.77 4.45 4.24 4.16 4.86 3.57 3.83 3.76 4.2 7.9 7.72
DPS(Rs) 0 0.57 0.57 0.57 0.57 0.57 0.53 0.89 0.89 0.89 1
Book NAV/Share(Rs) 20.96 24.11 27.2 30.23 33.97 36.32 39.1 41.2 43.81 50.12 56.08
Core EBITDA Margin(%) 10.3 11.49 11.24 12.29 13.54 10.85 10.31 9.02 11.02 15.66 14.71
EBIT Margin(%) 9.72 10.38 10.45 11.44 12.64 9.9 9.46 8.16 9.85 14.88 14.34
Pre Tax Margin(%) 7.97 8.59 8.46 9.51 10.59 7.32 7.61 6.49 7.95 13.28 12.6
PAT Margin (%) 7.23 7.94 7.76 8.9 10.57 7.25 7.61 6.38 6.34 11.35 10.45
Cash Profit Margin (%) 8.09 9.21 8.72 9.97 11.61 8.49 8.81 7.71 7.61 12.42 11.34
ROA(%) 10.9 9.99 8.7 8.46 9.81 5.83 5.86 5.14 5.43 10.49 9.71
ROE(%) 17.47 17.02 14.73 12.93 13.8 8.67 8.77 7.75 8.24 15.38 13.59
ROCE(%) 18.78 17.14 15.81 13.37 12.98 9.07 8.05 7.16 9.5 15.35 14.78
Receivable days 135.3 179.56 230.75 288.35 293.5 328.95 339.04 323.52 275.07 224.95 202.28
Inventory Days 45.47 46.61 34.02 28.43 30.47 40.63 42.74 46.71 70.91 102.98 129.42
Payable days 57.12 60.47 49.75 48.26 38.45 61.88 64.57 45.45 56.91 40.99 24.48
PER(x) 0 0 0 0 0 0 0 0 0 0 0
Price/Book(x) 0 0 0 0 0 0 0 0 0 0 0
Dividend Yield(%) 0 0 0 0 0 0 0 0 0 0 0
EV/Net Sales(x) 0.2 0.2 0.18 0.26 0.29 0.35 0.39 0.39 0.29 0.29 0.31
EV/Core EBITDA(x) 1.86 1.74 1.56 2.07 2.13 3.16 3.7 4.08 2.59 1.84 2.06
Net Sales Growth(%) 3.35 3.68 0.72 -14.35 0.49 0.31 3.41 12.23 13.26 15.19 10.26
EBIT Growth(%) 5.56 10.71 1.37 -6.19 11.01 -21.41 -1.21 -3.21 36.71 74.02 6.25
PAT Growth(%) 6.14 13.9 -1.48 -1.8 19.34 -31.2 8.55 -5.99 12.56 106.34 1.54
EPS Growth(%) 6.14 13.9 -1.48 -1.8 19.34 -31.2 8.55 -5.99 12.56 106.34 -1.51
Debt/Equity(x) 0.31 0.29 0.22 0.26 0.28 0.33 0.37 0.39 0.3 0.32 0.21
Current Ratio(x) 2.2 2.19 2.18 3.27 3.59 3.48 5.52 4.25 4.04 4.22 4.21
Quick Ratio(x) 1.74 1.82 2.02 2.96 3.3 3.07 5.05 3.65 3.1 2.77 2.57
Interest Cover(x) 5.54 5.78 5.25 5.92 6.15 3.83 5.12 4.9 5.19 9.28 8.26
Total Debt/Mcap(x) 0 0 0 0 0 0 0 0 0 0 0

Sihora Industries Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 11% 13% 11% 4%
Operating Profit CAGR 0% 29% 16% 8%
PAT CAGR 10% 30% 22% 8%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR NA% NA% NA% NA%
ROE Average 14% 12% 11% 13%
ROCE Average 15% 13% 11% 13%

Company Contact Information

Sheel Biotech Ltd.

Anupam Pandey

+91 88511 - 89801

compliance@sheelbiotech.com

8 Balaji Estates, 2nd Floor Block- C, Guru Ravidas Marg Kalkaji, South Delhi

IPO Lead Manager(s)

Sheel Biotech Ltd.

Narnolia Financial Services Ltd.

Registrar Info

Sheel Biotech Ltd.

Skyline Financial Services Pvt Ltd

D-153/A, 1st Floor,Okhla Industrial Area, Phase - I, New Delhi - 110020

91-011-26812682/84

91-11-26292681

admin@skylinerta.com

Frequently Asked Questions

All You Need To Know About IPO

When you leave without vesting, generally unvested ESOPs are cancelled. Vested ESOPs usually can be exercised after you depart, often within 3 to 6 months, depending on the company's ESOP plan.

For companies listed on a stock exchange, you can sell the shares any time after you exercise the ESOP option and the shares are in your demat account. If the company is unlisted or otherwise a startup, you can only sell the shares if and when the company announces a buyback or has a process for secondary sales.

Whenever you exercised your options to hold shares, you entered into a market risk situation, and if the valuation of the company drops, so do the shares.

Yes. ESOPs are valuable to the employer in that the employer is able to retain the best talent, align employee interests with company goals, and preserve cash while rewarding performance.

Wealth Icon
Don’t Miss Out on Unlisted Shares

Open your account today and gain instant access to top unlisted shares and pre-IPO opportunities.

whatsapp

Error!